TRDMT1: A Drug Target / Disease Biomarker (G1787)

Target Name: TRDMT1

NCBI ID: G1787

TRDMT1

TRDMT1: A Drug Target / Disease Biomarker

TRDMT1, also known as NEDD8-activating enzyme 1, is a protein that is expressed in various tissues throughout the body. It is a key player in the neurotransmitter signaling pathway, which is responsible for transmitting signals from the brain to other parts of the body.

One of theTRDMT1 functions is to convert the neurotransmitter N-methyl-D-aspartate (NMDA) into another neurotransmitter, called N-methyl-D-tetrahydro-aspartate (NMDA), which is involved in pain signaling and neuroprotection.

In recent years, researchers have become interested in TRDMT1 as a potential drug target or biomarker for various neurological and psychiatric disorders, including chronic pain, anxiety, and depression.

One of the reasons for this interest is the fact that TRDMT1 is known to be involved in the regulation of pain signaling pathways. Studies have shown that TRDMT1 is involved in the production and degradation of NMDA, as well as its regulation by other molecules.

Additionally, TRDMT1 has been shown to play a role in the regulation of neuroprotection, which is the process by which the brain protects itself from harmful substances and conditions. This is important for the health and functioning of the brain, as damage to the nervous system can have serious consequences.

Another potential reason for TRDMT1's interest as a drug target is its role in the regulation of neurotransmitter signaling pathways. Neurotransmitters are chemical messengers that are used by the brain to communicate with other parts of the body.

TRDMT1 is involved in the production and degradation of several neurotransmitters, including dopamine, serotonin, and GABA. It has been shown that changes in the levels of these neurotransmitters can have a significant impact on mood, emotion, and other aspects of brain function.

Finally, TRDMT1 is also of interest as a potential biomarker for certain neurological disorders. For example, TRDMT1 has been shown to be involved in the regulation of pain signaling pathways, which can be affected in conditions such as chronic pain, anxiety, and depression.

In conclusion, TRDMT1 is a protein that is expressed in various tissues throughout the body that is involved in the neurotransmitter signaling pathway. It is expressed in high levels in the brain and has been shown to play a role in the production and regulation of several neurotransmitters, as well as in the regulation of neuroprotection and pain signaling pathways.

These properties make TRDMT1 an attractive target for drug development for various neurological and psychiatric disorders. Further research is needed to fully understand the role of TRDMT1 in these processes and to develop effective treatments.

Protein Name: TRNA Aspartic Acid Methyltransferase 1

Functions: Specifically methylates cytosine 38 in the anticodon loop of tRNA(Asp)

The "TRDMT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRDMT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets